OncoSec Medical Closes $42.0 Million Public Offering of Common Stock Jan 25, 2021 04:00PM
Oncosec Medical (ONCS) Prices $42 Million Public Offering of Common Stock at $5.45/sh Jan 21, 2021 08:34AM
OncoSec Medical Announces Pricing of $42.0 Million Public Offering of Common Stock Jan 21, 2021 08:30AM
OncoSec Sets the Record Straight on Alpha Holdings’ False and Misleading Statements Dec 2, 2019 08:00AM
OncoSec Medical (ONCS) PT Lowered to $6 at Maxim Group Jul 31, 2019 08:26AM


May 28, 2019 08:30AM OncoSec Medical Incorporated Announces Closing of $11.0 Million Public Offering and Terminates ATM and Other Financing Facility
Mar 17, 2017 07:51AM Maxim Group Reiterates Buy Rating and $5 PT on Oncosec Medical (ONCS); 'Phase 2b of IL-12 Coming in 1h17'
Mar 7, 2017 09:22AM OncoSec to Present at Scientific and Investment Conferences in March
Jul 21, 2016 02:57PM OncoSec Medical (ONCS) PT Cut to $5 at Maxim Group, Keeps Buy
Jul 12, 2016 12:41PM Prima BioMed (PBMD) Immunotherapy Delivery Method Looks Promising - Maxim Group
May 26, 2016 08:12PM OncoSec Closes $10 Million At-The-Market Registered Direct Offering
Nov 9, 2015 04:05PM OncoSec Medical Closes $7.5 Million Registered Direct Offering
Nov 3, 2015 08:00PM OncoSec Announces $7.5 Million Registered Direct Offering
Jun 9, 2015 06:46AM Oncosec Medical (ONCS) Reports Wider Nine-Month Loss of $1.19/Share for 2015; Closes Direct Offering
Jun 8, 2015 05:27PM OncoSec Medical Closes $13.6 Million Registered Direct Offering
Jun 3, 2015 09:43AM Oncosec Medical Incorporated (ONCS) Enters 2.47M Common Direct Offering at $5.50/Share
Jun 3, 2015 09:42AM OncoSec Medical Announces $13.6 Million Registered Direct Offering